Intervention of CD4+ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4Ig

Journal of Immunology

Volumn 156, Issue 3, 1996, Pages 1262-1268

  Chu, Elton B ^a,c   Hobbs, Monte V ^a   Wilson, Curtis B ^a   Romball, Carole G ^a   Linsley, Peter S ^b   Weigle, William O ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNITY; CELL MATURATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; LONGEVITY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CHROMATIN; FEMALE; GLOMERULONEPHRITIS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; INTERLEUKIN-2; L-SELECTIN; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, MUTANT STRAINS;

EID: 0030039652     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Theofilopoulos, A. N. 1992. Murine models of lupus. In Systemic Lupus Erythematosus, 2nd Ed. R. G Lahita, ed. Churchill Livingston, New York, p 121.
2. + cell subsets and lymphokine production in BXSB mice. J. Immunol. 152:4129.
3. Finck, B. K , P. S. Linsley, and D Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265:1225.
4. Brunet, J. F., F Denizot, M. F Luciani, M. Roux-Dosseto, M. Suzan, M G Matte, and P. Golstein 1987 A new member of the immunoglobulin super family, CTLA-4. Nature 328:267
5. Linsley, P. S , W Brady, M Urnes, L S. Grosmaire, N K. Damle, and J. A. Ledbetter, 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
6. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L Greene, J. A. Ledbetter, C. Singh, and M A, Tepper 1992 Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
7. + T cells correlates with shifts in the frequencies of cell subsets, defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression. J Immunol. 151:575.
8. Ernst, D. N., W. O. Weigle, D. N. McQuitty, A L. Rothermel, and M. V. Hobbs. 1989. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules. J. Immunol 142:1413
9. Rubin, R. L 1992. Enzyme-linked immunosorbent assay for anti-DNA and anti-histone antibodies including anti-(H2A-H2B) In Manual of Clinical Laboratory Immunology, 4th Ed. N R Rose, E. C. de Macario, J. L. Fahey, H. Friedman, and G. M Penn, eds American Society for Microbiology, Washington, D.C., p. 735.
10. Chomczynski, P , and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156
11. + T cells from young and old mice. J. Immunol. 150:3602
12. Snedecor, G W., and W. G Cochran. 1980. One-way classifications; analysis of variance. In Statistical Methods, 7th Ed Iowa State University Press, Ames, IA, p 215.
13. Giese, T., and W. F. Davidson. 1992. Evidence for early onset polyclonal activation of T cell subsets in mice homozygous for lpr J Immunol. 149:3097.
14. Budd, R. C., J.-C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R. C. Howe, and H. R. MacDonald. 1987. Distinction of virgin and memory T lymphocytes, stable acquisition of the Pgp-1 Glycoprotein concomitant with antigenic stimulation J. Immunol. 138:3120
15. Birkeland, M. L., P. Johnson, I S. Trowbridge, and E Pure 1989. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc. Natl. Acad Sci USA 86:6734.
16. Jung, T M , W. M. Gallatin, I. L. Weissman, and M. O. Dailey. 1988. Downregulation of homing receptors after T cell activation. J. Immunol. 141:4110.
17. Altman, A , A. N. Theofilopoulos, R. Weiner, D. H. Katz, and F. J. Dixon. 1981. Analysis of T cell function in autoimmune murine strains. Defects in production of and responsiveness to interleukin 2. J. Exp. Med. 154:791.
18. Andrews, B. S., R. A Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E D. Murphy, J. B. Roths, and F. J Dixon. 1978. Spontaneous murine lupus-like syndromes. J Exp. Med 148:1198.
19. Eisenberg, R. A , S Izui, P J. McConahey, L. M. Hang, C J. Peters, A N, Theofilopoulos, and F. J. Dixon. 1980. Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J. Immunol. 125:1032.
20. Weigle, W. O. 1993. The effect of aging on cytokine release and associated immunologic functions Immunological problems of the aged. Immunol. Allergy Clin North Am 13:551.
21. + T cells J. Immunol 154:1684
22. McArthur, J. G., and D. H. Raulet. 1993. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J. Exp. Med. 178:1645
23. Seder, R. A., R. N. Germain, P. S. Linsley, and W. E. Paul. 1994. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production. J. Exp. Med. 179:299.
24. Walker, S E. 1977. Accelerated mortality in young NZB/NZW mice treated with the interferon inducer Tilorone Hydrochloride. Clin. Immunol. Immunopathol. 8:204.
25. Adam, C., Y Thoua, P. Ronco, P. Verroust, M. Tovey, and L. Morel-Maroger 1980. The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice Clin. Exp. Immunol 40:373.
26. Hooks, J. J., G. W Jordan, T. Cupps. H M Moutsopoulos, A. S. Fauci, and A L Notkins. 1982. Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum. 25:396
27. Ytterberg, S. R., and T. J Schnitzer. 1982. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25:401.
28. Jacob, C O , P. H. VanderMeide, and H. O. McDevitt. 1987 In vivo treatment of (NZB X NZW) F1 lupus-like nephritis with monoclonal antibodies to γ-interferon. J. Exp. Med 166 798.
29. Ozmen, L., D. Roman, M Fountoulakis, G Schmid, B. Ryffel, and G. Garotta 1995. Experimental therapy of systemic lupus erythematosus the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis Eur. J Immunol 25:6.
30. + cells and cell subsets from young and old mice. Cell. Immunol 154:264.
31. 1 mice J. Exp. Med. 179:305.
32. Llorente, L., Y Richaud-Patin, J Wijdenes, J Alcocer-Varela, M.-C. Maillot, I. Durand-Gasselin, B. Morel-Fourrier, P. Galanaud, and D. Emilie. 1993 Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus Eur Cytokine Network 4:421
33. Llorente, L , W Zou, Y Levy, Y Richaud-Patin, J. Wijdenes, J, Alcocer-Varela, B, Morel-Fourrier, J.-C Brouet, D. Alarcon-Segovia, P. Galanaud, and D. Emilie 1995 Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus J. Exp. Med. 181:839
34. Lenschow, D. J., S. C. Ho, H. Sattar, L Rhee, G Gray, N. Nabavi, K C. Herold, and J. A. Bluestone. 1995 Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the non-obese diabetic mouse. J. Exp. Med. 181 1145
35. Nishikawa, K., P S. Linsley, A B Collins, I Stamenkovic, R T. McCluskey, and G. Andres. 1994. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis Eur. J. Immunol. 24, 1249
36. Kuchroo, V. K., M. P. Das, J. A. Brown, A M Ranger, S S Zamvil, R. A Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways application to autoimmune disease therapy Cell 80:707.